• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病和术后黏液潴留对可治愈性切除的非小细胞肺癌患者预后的长期影响。

The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.

机构信息

Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.

Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.

出版信息

Cells. 2023 Feb 2;12(3):480. doi: 10.3390/cells12030480.

DOI:10.3390/cells12030480
PMID:36766822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9914637/
Abstract

Chronic obstructive pulmonary disease (COPD) serves as risk factor for the development of lung cancer and seems to have a prognostic impact after surgery for non-small cell lung cancer (NSCLC). The aim was to investigate the impact of COPD and postoperative mucostasis on the long-term survival after resected NSCLC. We retrospectively reviewed the data from 342 patients with curatively resected NSCLC. The prognostic long-term impact of COPD and postoperative mucostasis on overall survival (OS), recurrence free survival (RFS) and cancer specific survival (CSS) was calculated using univariable and multivariable Cox regression analyses. We found that 52.3% suffered from COPD and 25.4% had postoperative mucostasis. COPD was significantly more common among smokers (59.9%) compared with non-smokers (21.3%), ( < 0.001). There was a significant relationship between COPD and postoperative mucostasis ( = 0.006) and between smoking and mucostasis ( = 0.023). Patients with postoperative mucostasis had a significantly worse OS ( < 0.001), RFS ( = 0.009) and CSS ( = 0.008). The present analysis demonstrated that postoperative mucostasis, but not COPD, was associated with both worse short- and long-term outcomes for OS, RFS and CSS in curatively resected NSCLC.

摘要

慢性阻塞性肺疾病(COPD)是肺癌发生的危险因素,并且似乎对非小细胞肺癌(NSCLC)手术后的预后有影响。本研究旨在探讨 COPD 和术后黏液阻塞对 NSCLC 切除后长期生存的影响。我们回顾性分析了 342 例接受根治性 NSCLC 手术的患者的数据。使用单变量和多变量 Cox 回归分析计算 COPD 和术后黏液阻塞对总生存(OS)、无复发生存(RFS)和癌症特异性生存(CSS)的预后长期影响。我们发现,52.3%的患者患有 COPD,25.4%的患者发生术后黏液阻塞。与不吸烟者(21.3%)相比,吸烟者(59.9%)中 COPD 更为常见(<0.001)。COPD 与术后黏液阻塞(=0.006)以及吸烟与黏液阻塞(=0.023)之间存在显著关系。发生术后黏液阻塞的患者 OS(<0.001)、RFS(=0.009)和 CSS(=0.008)明显更差。本分析表明,术后黏液阻塞与 NSCLC 根治性切除术后 OS、RFS 和 CSS 的短期和长期预后较差相关,而 COPD 则无此相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd8/9914637/66e85ab05089/cells-12-00480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd8/9914637/66e85ab05089/cells-12-00480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd8/9914637/66e85ab05089/cells-12-00480-g001.jpg

相似文献

1
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.慢性阻塞性肺疾病和术后黏液潴留对可治愈性切除的非小细胞肺癌患者预后的长期影响。
Cells. 2023 Feb 2;12(3):480. doi: 10.3390/cells12030480.
2
[Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].[慢性阻塞性肺疾病对非小细胞肺癌切除术后患者复发风险的影响]
Zhongguo Fei Ai Za Zhi. 2018 Mar 20;21(3):215-220. doi: 10.3779/j.issn.1009-3419.2018.03.21.
3
The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: a comparison with smokers.阻塞性肺疾病对接受手术的非小细胞肺癌不吸烟者生存的预后影响:与吸烟者的比较
Interact Cardiovasc Thorac Surg. 2019 May 1;28(5):735-743. doi: 10.1093/icvts/ivy329.
4
Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.慢性阻塞性肺疾病对非小细胞肺癌切除术后复发的影响。
Int J Chron Obstruct Pulmon Dis. 2015 Dec 29;11:43-9. doi: 10.2147/COPD.S97411. eCollection 2016.
5
Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.慢性阻塞性肺疾病(COPD)对非小细胞肺癌(NSCLC)手术患者肺部并发症及长期生存的影响。
Lung Cancer. 2002 Jul;37(1):95-101. doi: 10.1016/s0169-5002(02)00014-4.
6
Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched Analysis.慢性阻塞性肺疾病对非小细胞肺癌患者行肺叶切除术长期预后的影响:倾向评分匹配分析。
Anticancer Res. 2023 Nov;43(11):5215-5222. doi: 10.21873/anticanres.16723.
7
Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.肺癌合并重度慢性阻塞性肺疾病患者的长期手术结局
Thorac Cardiovasc Surg. 2009 Sep;57(6):339-42. doi: 10.1055/s-0029-1185571. Epub 2009 Aug 25.
8
Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter.接受解剖性切除的Ⅰ期非小细胞肺癌中的慢性阻塞性肺疾病:作为复发促进因素的作用
COPD. 2014 Aug;11(4):407-13. doi: 10.3109/15412555.2013.838946. Epub 2014 Jan 29.
9
Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.非小细胞肺癌肺切除术后接受随访的慢性阻塞性肺疾病患者因心血管和呼吸系统原因导致的死亡风险。
J Cardiovasc Surg (Torino). 2007 Jun;48(3):375-83.
10
Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.重度至极重度慢性阻塞性肺疾病对接受化疗的非小细胞肺癌患者预后的影响。
Clin Respir J. 2020 Apr;14(4):345-352. doi: 10.1111/crj.13139. Epub 2020 Jan 3.

引用本文的文献

1
Development and validation of a nomogram for predicting 90-day mortality in patients with advanced lung cancer based on inflammatory and nutritional biomarkers.基于炎症和营养生物标志物的晚期肺癌患者90天死亡率预测列线图的开发与验证
Am J Cancer Res. 2025 Aug 15;15(8):3570-3587. doi: 10.62347/RNYP8960. eCollection 2025.
2
Effect analysis of flexible bronchoscopy in thoracoscopic surgery for congenital pulmonary airway malformation.软性支气管镜在先天性肺气道畸形胸腔镜手术中的效果分析
Medicine (Baltimore). 2025 Aug 1;104(31):e43635. doi: 10.1097/MD.0000000000043635.
3
The prognostic significance of modified frailty index-5 in patients undergoing pneumonectomy for lung cancer.

本文引用的文献

1
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes.COPD 和肺癌中的免疫景观的意义:吸烟与其他原因。
Front Immunol. 2022 Mar 21;13:846605. doi: 10.3389/fimmu.2022.846605. eCollection 2022.
2
The Overweight Paradox: Impact of Body Mass Index on Patients Undergoing VATS Lobectomy or Segmentectomy.超重悖论:体重指数对接受电视辅助胸腔镜肺叶切除术或肺段切除术患者的影响。
Semin Thorac Cardiovasc Surg. 2023 Spring;35(1):164-176. doi: 10.1053/j.semtcvs.2022.02.004. Epub 2022 Feb 17.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
改良虚弱指数-5在肺癌肺切除患者中的预后意义。
Interdiscip Cardiovasc Thorac Surg. 2024 Nov 6;39(5). doi: 10.1093/icvts/ivae179.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.非小细胞肺癌手术后十年复发、第二原发肿瘤或其他肿瘤的风险。
Clin Lung Cancer. 2020 Jul;21(4):333-340. doi: 10.1016/j.cllc.2020.02.011. Epub 2020 Feb 26.
5
Surgical outcomes and prognosis of non-small-cell lung cancer in patients with chronic lung diseases: a retrospective analysis.慢性肺部疾病患者非小细胞肺癌的手术结果及预后:一项回顾性分析
Eur J Cardiothorac Surg. 2020 Aug 1;58(2):357-364. doi: 10.1093/ejcts/ezaa060.
6
Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score.以术前格拉斯哥预后评分预测I期非小细胞肺癌切除术后临床结局
Cancers (Basel). 2020 Jan 8;12(1):152. doi: 10.3390/cancers12010152.
7
The prognosis of non-small cell lung cancer combined with chronic obstructive pulmonary disease: A systematic review and meta-analysis.非小细胞肺癌合并慢性阻塞性肺疾病的预后:系统评价和荟萃分析。
Clin Respir J. 2020 Apr;14(4):389-396. doi: 10.1111/crj.13144. Epub 2020 Feb 3.
8
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.非小细胞肺癌:流行病学、筛查、诊断和治疗。
Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013.
9
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.比较肺功能诊断的慢性阻塞性肺疾病(COPD)和非 COPD 从不吸烟的 I-IV 期非小细胞肺癌患者的临床特征和总生存期。
Int J Chron Obstruct Pulmon Dis. 2019 May 1;14:929-938. doi: 10.2147/COPD.S190244. eCollection 2019.
10
Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.慢性阻塞性肺疾病和合并症对非小细胞肺癌患者死亡率的影响。
Acta Oncol. 2019 Aug;58(8):1102-1106. doi: 10.1080/0284186X.2019.1612942. Epub 2019 May 15.